Discussion 'Clinical Trials'
Expanding Role of mRNA Platform with Nobel Laureate Dr. Drew Weissman
We are excited to welcome Nobel Laureate Dr. Drew Weissman from the University of Pennsylvania yet again on CureTalks. Dr.Weissman's groundbreaking research in messenger RNA (mRNA) technology earned him the Nobel Prize in Medicine, alongside his colleague Katalin Karikó. Their…
What is Fibrodysplasia Ossificans Progressiva (FOP)? Exploring the Rare Genetic Disorder with Leading Experts
Fibrodysplasia ossificans progressiva (FOP) is an ultra rare disease, where soft tissues progressively turn into bone. FOP affects approximately 1 in 2 million people worldwide. This condition is caused by a mutation in the ACVR1 gene, which disrupts the body’s…
Rh Sensitization in Pregnancy – Current Guidelines & Advances in Management
The presence or absence of the Rh antigen on human red blood cells determines if a person's blood type is "positive" or "negative." When an Rh-negative individual, who lacks this antigen, becomes pregnant and carries an Rh-positive fetus, the mother's…
When should people get palliative care?
Palliative care is specialized medical care focused on relieving the symptoms and stress of a serious illness and improving quality of life, in alignment with a patient’s individual goals, values, and priorities. Although palliative care consultation is recommended for millions…
Unraveling the Complexities of BRCA-Related Breast and Ovarian Cancers
The BRCA1 (BReast CAncer gene 1) and BRCA2 are genes that produce proteins crucial for DNA repair. Since these proteins play a pivotal role in cellular resilience against DNA damage — mutations leading to inactivation of these genes results in…